Last reviewed · How we verify
short-course antibiotic treatment — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
short-course antibiotic treatment (short-course antibiotic treatment) — Rabin Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| short-course antibiotic treatment TARGET | short-course antibiotic treatment | Rabin Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- short-course antibiotic treatment CI watch — RSS
- short-course antibiotic treatment CI watch — Atom
- short-course antibiotic treatment CI watch — JSON
- short-course antibiotic treatment alone — RSS
Cite this brief
Drug Landscape (2026). short-course antibiotic treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/short-course-antibiotic-treatment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab